Vizora日本語

noevir holdingsnoevir holdings co.,ltd.4928東証プライム化学FY ending Sep 2025, consolidated, J-GAAP

noevir holdings FY ending Sep 2023 results

About 77% of noevir holdings's sales come from Cosmetics, with Medicine and grocery and Other making up much of the rest.

Out of every ¥100 of sales, about ¥18 is left as operating profit.

Revenue changed +2.3% from the prior year, operating profit +9.0%.

Revenue and profit pattern

Revenue and profit upProfit grew faster

Revenue +2.3% · profit +9.0%, calculated from disclosed figures.

Operating leverage: 3.90× (profit growth ÷ revenue growth)

What changed from last year

FY ending Sep 2022 → FY ending Sep 2023

Revenue
+2.3%¥61.1B → ¥62.6B
Gross profit
+1.1%¥42.1B → ¥42.6B
Operating income
+9.0%¥10.1B → ¥11B
Net income attributable to owners
+1.1%¥7.59B → ¥7.67B
Operating cash flow
+30.4%¥5.84B → ¥7.62B
Free cash flow
+25.6%¥5.23B → ¥6.57B

Where the money goes

FY ending Sep 2022 → FY ending Sep 2023

Where ¥100 of sales goes

For every ¥100 noevir holdings sells, how much goes where, and how much is kept.

FY ending Sep 2023
Cost of sales
¥32
SG&A
¥50
Operating profit
¥18
Net profit kept
¥12

Annual margin trends

Gross margin68.0%
FY ending Sep 2019: 64.5%64.5%FY ending Sep 2020: 63.8%63.8%FY ending Sep 2021: 64.4%64.4%FY ending Sep 2022: 68.8%68.8%FY ending Sep 2023: 68.0%68.0%FY19FY20FY21FY22FY23
Operating margin17.6%
FY ending Sep 2019: 20.2%20.2%FY ending Sep 2020: 15.5%15.5%FY ending Sep 2021: 16.7%16.7%FY ending Sep 2022: 16.5%16.5%FY ending Sep 2023: 17.6%17.6%FY19FY20FY21FY22FY23
Net margin12.3%
FY ending Sep 2019: 12.2%12.2%FY ending Sep 2020: 10.8%10.8%FY ending Sep 2021: 12.4%12.4%FY ending Sep 2022: 12.4%12.4%FY ending Sep 2023: 12.3%12.3%FY19FY20FY21FY22FY23

Aligned fiscal years compare the shares of revenue remaining as gross, core, and net profit. Missing years are left unconnected.

Which businesses earn the money

Revenue by business segment, and the profit each one keeps.

FY ending Sep 2023

Profit by segment

※ Segment figures include inter-segment sales and do not sum to the company total

Sources

Show source documents (6)

  • EDINET (FSA Japan)

    有価証券報告書－第15期(2024/10/01－2025/09/30)

    ID S100X8TQ2025-12-08Open

  • EDINET (FSA Japan)

    訂正有価証券報告書－第14期(2023/10/01－2024/09/30)

    ID S100WQSD2025-09-25Open

  • EDINET (FSA Japan)

    有価証券報告書－第13期(2022/10/01－2023/09/30)

    ID S100SEXP2023-12-08Open

  • EDINET (FSA Japan)

    訂正有価証券報告書－第12期(令和3年10月1日－令和4年9月30日)

    ID S100PS6R2022-12-12Open

  • EDINET (FSA Japan)

    有価証券報告書－第11期(令和2年10月1日－令和3年9月30日)

    ID S100MYPB2021-12-06Open

  • EDINET (FSA Japan)

    有価証券報告書－第10期(令和1年10月1日－令和2年9月30日)

    ID S100KAP22020-12-04Open

Extracted from XBRL: 52 / Derived from other figures: 1

Spotted an error? Report it (corrections keep the original record)

Other periods

Analyze this page with AI

Markdown with figures, units, periods and sources, ready to paste into ChatGPT or Claude.

Open MarkdownShare on XSave image